Liminatus Pharma, Class Stock Alpha and Beta Analysis
| LIMN Stock | 0.65 0.06 8.45% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Liminatus Pharma, Class. It also helps investors analyze the systematic and unsystematic risks associated with investing in Liminatus Pharma, over a specified time horizon. Remember, high Liminatus Pharma,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Liminatus Pharma,'s market risk premium analysis include:
Beta 1.39 | Alpha (1.04) | Risk 6.92 | Sharpe Ratio (0.17) | Expected Return (1.21) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Liminatus | Build AI portfolio with Liminatus Stock |
Liminatus Pharma, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Liminatus Pharma, market risk premium is the additional return an investor will receive from holding Liminatus Pharma, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Liminatus Pharma,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Liminatus Pharma,'s performance over market.| α | -1.04 | β | 1.39 |
Liminatus Pharma, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Liminatus Pharma,'s Buy-and-hold return. Our buy-and-hold chart shows how Liminatus Pharma, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Liminatus Pharma, Market Price Analysis
Market price analysis indicators help investors to evaluate how Liminatus Pharma, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Liminatus Pharma, shares will generate the highest return on investment. By understating and applying Liminatus Pharma, stock market price indicators, traders can identify Liminatus Pharma, position entry and exit signals to maximize returns.
Liminatus Pharma, Return and Market Media
The median price of Liminatus Pharma, for the period between Sun, Sep 28, 2025 and Sat, Dec 27, 2025 is 1.17 with a coefficient of variation of 26.26. The daily time series for the period is distributed with a sample standard deviation of 0.31, arithmetic mean of 1.16, and mean deviation of 0.25. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Liminatus Pharma, Inc. Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation | 10/30/2025 |
2 | Signal strength of Liminatus Pharma Inc. stock in tech scanners - Trade Signal Summary High Accuracy Trade Alerts - newser.com | 11/10/2025 |
3 | Head to Head Review Prime Medicine versus Liminatus Pharma | 12/03/2025 |
4 | Is Liminatus Pharma Inc. Equity Warrant stock a buy for dividend growth - Dollar Strength Verified High Yield Trade Plans - ulpravda.ru | 12/18/2025 |
About Liminatus Pharma, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Liminatus or other stocks. Alpha measures the amount that position in Liminatus Pharma, Class has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Liminatus Pharma, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Liminatus Pharma,'s short interest history, or implied volatility extrapolated from Liminatus Pharma, options trading.
Build Portfolio with Liminatus Pharma,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Liminatus Pharma, Backtesting, Liminatus Pharma, Valuation, Liminatus Pharma, Correlation, Liminatus Pharma, Hype Analysis, Liminatus Pharma, Volatility, Liminatus Pharma, History and analyze Liminatus Pharma, Performance. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Liminatus Pharma, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.